Variable | Non-Concomitant CABG (N = 377) | Concomitant CABG (N = 42) | Overall (N = 419) | p-value |
---|---|---|---|---|
Demographics | ||||
Age | 60.4 [49.3–69] | 68.1 [65.5–72.8] | 62 [50.3–69.6] | < 0.001 |
Gender | 285 (75.6%) | 34 (81%) | 319 (76.1%) | 0.567 |
Race | 0.519 | |||
Caucasian | 305 (81.6%) | 35 (83.3%) | 340 (81.1%) | |
Hispanic | 33 (8.8%) | 3 (7.1%) | 36 (8.6%) | |
Asian | 7 (1.9%) | 1 (2.4%) | 8 (1.9%) | |
African American | 21 (5.6%) | 2 (4.8%) | 23 (5.5%) | |
Middle Eastern | 1 (0.3%) | 1 (2.4%) | 2 (0.5%) | |
Other | 7 (1.9%) | 0 (0.0%) | 7 (1.7%) | |
Baseline Blood Pressure | ||||
Baseline SBP | 128 [117–138.2] | 132 [119–144.2] | 129 [118–139.8] | 0.184 |
Baseline DBP | 76 [68–86] | 76 [69.2–84.8] | 76 [68–86] | 0.992 |
Baseline A1c | 5.5 [5.3–5.9] | 5.8 [5.3–6.2] | 5.5 [5.3–5.9] | 0.106 |
BMI | 27.5 [24.4–31.3] | 28 [24.4–34.5] | 27.5 [24.4–31.9] | 0.537 |
Medical Comorbidities | ||||
Hyperlipidemia | 136 (36.1%) | 28 (66.7%) | 164 (39.1%) | < 0.001 |
Hypertension | 223 (59.2%) | 39 (92.9%) | 262 (62.5%) | < 0.001 |
Smoking | 93 (24.7%) | 9 (21.4%) | 102 (24.3%) | 0.784 |
Type 2 Diabetes Mellitus | 33 (8.8%) | 14 (33.3%) | 47 (11.2%) | < 0.001 |
Chronic Kidney Disease | 30 (8%) | 4 (9.5%) | 34 (8.1%) | 0.764 |
Peripheral Artery Disease | 4 (1.1%) | 3 (7.1%) | 7 (1.7%) | 0.025 |
Obesity | 130 (34.5%) | 18 (42.9%) | 148 (35.3%) | 0.364 |
Stroke | 18 (4.8%) | 2 (4.8%) | 20 (4.8%) | 1.000 |
Liver disease | 5 (1.3%) | 2 (4.8%) | 7 (1.7%) | 0.149 |
Pulmonary Disease | 79 (21%) | 16 (38.1%) | 95 (22.7%) | 0.020 |
Atrial Fibrillation | 22 (5.8%) | 8 (19%) | 30 (7.2%) | 0.006 |
Preop LVEF | 58.5 [51.4–65.9] | 59 [54.2–63.5] | 58.6 [51.7–65.6] | 0.845 |
Preop Carotid Imaging (US or CT) | 94 (24.9%) | 10 (23.8%) | 104 (24.8%) | 1.000 |
Carotid Stenosis > 70% | 3 (3.3%) | 0 (0.0%) | 3 (0.7%) | 1.000 |
Prior Cardiac Surgery | 63 (16.7%) | 7 (16.7%) | 70 (16.7%) | 1.000 |
Prior Aortic Surgery | 49 (13%) | 4 (9.5%) | 53 (12.6%) | 0.691 |